Journals / Kocatepe Veteriner Dergisi / 2020 / Cilt: 13 - Sayı: 3

Equine Adipose Tissue Derived Mesenchymal Stem Cells and Their Multilineage Differentiation

At Yağ Dokusu Kaynaklı Mezenkimal Kök Hücrelerin İzolasyonu ve Çoklu Farklılaştırması

Pages
304–312
Publication Date
2020-09-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Nonetheless, there is a still need to molecular characterization of EASCs in order to establish a standard practice in equine medicine.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Mesenchymal stem cells (MSCs) have become a potent source for cell therapy due their inherent properties of self-renewal and ability to undergo unlimited divisions in the field of regenerative medicine.
📊
Key Findings & Data:In this study, equine adipose tissue stem cells (EASCs) have been evaluated on the basis of their morphology, proliferation potential and multilineage differentiation capabilities for their future usage in cell therapy.
💡
Conclusion & Impact:Nonetheless, there is a still need to molecular characterization of EASCs in order to establish a standard practice in equine medicine.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Morfoloji · Çoklu farklılaştırma · Nörosfer

Abstract

Mesenchymal stem cells (MSCs) have become a potent source for cell therapy due their inherent properties of self-renewal and ability to undergo unlimited divisions in the field of regenerative medicine. In this study, equine adipose tissue stem cells (EASCs) have been evaluated on the basis of their morphology, proliferation potential and multilineage differentiation capabilities for their future usage in cell therapy. The cells were further differentiated into osteogenic and adipogenic cell lineages as well as into adipose derived neurospheres to ensure the stemness of propagated cells. In our study, we further successfully cultured the neurosphere derived cells which were cultured from neurospheres after enzymatic dissociation. The study exhibits that EASCs offer a suitable choice for cellular regenerative therapy in equines. Nonetheless, there is a still need to molecular characterization of EASCs in order to establish a standard practice in equine medicine.

Özet

Mezenkimal kök hücreler kendilerini yenileyebilme ve sınırsız bölünebilme kabiliyetlerinin vasıtasıyla rejeneratif tıp alanında etkili bir kaynak haline gelmiştir. Bu çalışmada at yağ dokusu kaynaklı mezenkimal kök hücreler (EASCs) gelecekte hücresel tedavilerde kullanılabilirliği adına, morfolojileri ve çoklu farklılaşma kabiliyetleri bakımından değerlendirmeye alınmıştır. Elde edilen hücrelerin kök hücre özelliğini kesinleştirmek için hücreler osteojenik ve adipojenik farklılaştırmaya tabii tutulmuş ve nörosfer farklılaştırması yapılmıştır. Bunun yanı sıra, çalışmada elde edilen nörosferlerin enzimatik olarak çözülümünden sonra elde edilen nörosfer kaynaklı hücreler kültüre edilmiştir. Çalışma at yağ dokusu kaynaklı kök hücrelerin atlarda rejeneratif tıp için uygun bir seçim olabileceğini öne sürmektedir. Fakat at hekimliğinde pratik uygulama için bir standardın oluşturulmasından önce daha detaylı moleküler karakterizasyon çalışmalarına ihtiyaç duyulmaktadır.

🔖

Cite This Article

KIBRIA, A. G., NAWAZ, S., DİKMEN, T., AKKAYA, Ö. Ö., YAĞCI, A. (2020). Equine Adipose Tissue Derived Mesenchymal Stem Cells and Their Multilineage Differentiation. Kocatepe Veteriner Dergisi, Cilt: 13 - Sayı: 3, 304–312. https://ajindex.com/articles/124629

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Alipour F, Parham A, Kazemi Mehrjerdi H, Dehghani H. Equine adipose-derived mesenchymal stem cells: phenotype and growth characteristics, gene expression profile and differentiation potentials. Cell journal.2015; 16(4): 456-465
  2. Altunbaş K, YaprakçI MV, S. Ç k. Isolation and Characterization of Olfactory Stem Cells from Canine Olfactory Mucosa. Kafkas Univ Vet Fak Derg,.2016; 22(2): 237-243
  3. Angelone M, Conti V, Biacca C, Battaglia B, Pecorari L, Piana F, Gnudi G, Leonardi F. The contribution of adipose tissue-derived mesenchymal stem cells and platelet-rich plasma to the treatment of chronic equine laminitis: A proof of concept. 2017; 18. Barberini D J, Freitas N P P, Magnoni M S, Maia L, Listoni A J, Heckler M C, Sudano M J, Golim M A, da Cruz Landim-Alvarenga F, Amorim R M. Equine mesenchymal stem cells from bone marrow, adipose tissue and umbilical cord: immunophenotypic characterization and differentiation potential. Stem Cell Res Ther.2014; 5(1): 25-25
  4. Barberini DJ, Aleman M, Aristizabal F, Spriet M, Clark KC, Walker NJ, Galuppo LD, Amorim RM, Woolard KD, Borjesson DL. Safety and tracking of intrathecal allogeneic mesenchymal stem cell transplantation in healthy and diseased horses. Stem Cell Res Ther. 2018; 9: 96. Biehl J K, Russell B. Introduction to stem cell therapy. The Journal of cardiovas nurs.2009; 24(2): 98-105
  5. Brederlau A, Correia A S, Anisimov S V, Elmi M, Paul G, Roybon L, Morizane A, Bergquist F, Riebe I, Nannmark U, Carta M, Hanse E, Takahashi J, Sasai Y, Funa K, Brundin P, Eriksson P S, Li J-Y. Transplantation of Human Embryonic Stem Cell-Derived Cells to a Rat Model of Parkinson's Disease: Effect of In Vitro Differentiation on Graft Survival and Teratoma Formation. Stem Cell.2006; 24(6): 1433-1440
  6. Burk J, Ribitsch I, Gittel C, Juelke H, Kasper C, Staszyk C, Brehm W. Growth and differentiation characteristics of equine mesenchymal stromal cells derived from different sources. Vet journal. 2013; 195(1): 98-106
  7. Byrne J A, Pedersen D A, Clepper L L, Nelson M, Sanger W G, Gokhale S, Wolf D P, Mitalipov S M. Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature.2007; 450(7169): 497-502
  8. Chen S, Cui G, Peng C, Lavin MF, Sun X, Zhang E, Yang Y, Guan Y, Du Z, Shao H. Transplantation of adipose-derived mesenchymal stem cells attenuates pulmonary fibrosis of silicosis via anti-inflammatory and anti-apoptosis effects in rats. Stem Cell Res Ther. 2018; 9: 110. Crovace A, Lacitignola L, Rossi G, Francioso E. Histological an